The UK Black Pharmacist Association (UKBPA) – A message from board member Titilayo Alagbe

Titilayo Alagbe, Co-Chair of The BOPA Independent Sector Oncology Pharmacy (BISOP) Group has joined the UK Black Pharmacist Association (UKBPA) as a board member.  The Mission and Vision is to encourage ALL Black Pharmacists across all sectors to join and let us build and support UK Black Pharmacists, pharmacist in training and students.

“Our mission is simple to empower Black pharmacists, trainee pharmacists, and students by shedding light on the factors that limit their choices and opportunities.  We aim to amplify their voices and experiences to drive real change and reduce racial discrimination in the field of pharmacy. Join us in our advocacy for a more inclusive and equitable future”

If you would like to hear more about the UKBPA, join the group and collaborate with UKBPA on behalf of BOPA just let Titilayo know on: [email protected]

For more information visit the UKBPA website here: Uk Black Pharmacist Association | Ukbpa Site

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article